Spencer Pharmaceutical (SPPH)

[BS123]

The following is a response that I recieved from Strategema Capital:




Thank you for your Email of the 22 November, and my apologies for not reverting to you sooner.



We have indeed been recently retained as third parties to assist in the assessment of various cash buyouts for Spencer Pharma. However, we do not have any details from the company at present in respect to the current transaction which you mention. I understand from Dr Arella that there have been certain initial discussions with the company and that a meeting is due in Montreal with Al-Dora representatives on the 29-30th November. Once that meeting is taken place I am informed by Dr Arella that will be provided with details and documentation of the transaction in question.



I trust the above is in order.



With kind regards



Yours sincerely



Maurice Hennequin

Partner



Strategema Capital SA

1-3 Rue de Chantepoulet

1201, Geneva

Switzerland



Tel: [phone]

Fax: [phone]

Mob: [phone]

Skype: stratcap



[e-mail]

www.strategema-capital.com